Our goal is the development of novel targeted immunological and epigenetic concepts in the treatment of solid tumors and hematological malignancies, which will give rise to subsequent translational study programs, which will be carried out in close cooperation with the Department of Hematology/Oncology at the Saarland University Medical Center.
